The aim of this multicenter, prospective analysis was to determine the long-term outcomes of treatment of MPS VI patients with galsulfase beginning in infancy.
A true diagnosis of Fabry disease may be delayed or the condition may be completely misdiagnosed, as it often masquerades as a rheumatological disease.
Currently, there are no approved treatments for MLD, a lysosomal storage disease caused by a deficiency in arylsulfatase A.
Patients with Gaucher disease do not appear to be at increased risk for SARS-CoV-2 infection, according to findings presented at the 17th Annual WORLDSymposium.
In preclinical studies, hydroxypropyl beta cyclodextrin has been shown to transport cholesterol from cells, normalizing cholesterol metabolism.
GD3 is a chronic neuropathic form of Gaucher disease characterized by progressive encephalopathy.
The extension study included a total of 84 adult FD patients who completed the FACETS, ATTRACT, or AT1001-041 study.
ASMD is a rare, debilitating lysosomal storage disease characterized by a deficiency of the enzyme acid sphingomyelinase, which results in the accumulation of sphingomyelin in various tissues of the body.
The patient, who was initially diagnosed with Gaucher disease type 1 during her first pregnancy 20 years prior, presented with bleeding, hematomas, and thrombocytopenia, in addition to hepatomegaly, splenomegaly, and bone marrow infiltration.
Arimoclomol is a small molecule designed to amplify and sustain the cellular production of heat shock proteins, particularly HSP70, which targets protein misfolding and improves lysosomal function.
Want to read more?
Please login or register first to view this content.